LitAlert ~~ GeneLit.com

    • BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms.
    • Devico Marciano N, Kroening G, Dayyani F, Zell JA, Lee FC, Cho M, Goldstein Valerin J.
    • Cancers (Basel). 2022 May 16;14(10):2453. doi: 10.3390/cancers14102453.
    • Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups.
    • Witjes VM, Braspenning JCC, Hoogerbrugge N, Smolders YHCM, Hermkens DMA, Mourits MJE, Ligtenberg MJL, Ausems MGEM, de Hullu JA.
    • Fam Cancer. 2022 May 16. doi: 10.1007/s10689-022-00294-0. Epub ahead of print.
    • Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers.
    • Paolino G, Pampena R, Di Nicola MR, Longo C, Rognone A, Zambelli S, Bianchini G, Mercuri SR.
    • Front Med (Lausanne). 2022 Apr 29;9:863468. doi: 10.3389/fmed.2022.863468.
    • Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record.
    • Elhanan G, Kiser D, Neveux I, Dabe S, Bolze A, Metcalf WJ, Lu JT, Grzymski JJ.
    • Front Genet. 2022 Apr 27;13:866169. doi: 10.3389/fgene.2022.866169.
    • Genetic testing for hereditary predisposition to breast cancer in the real world: Initial experience.
    • da Silva Fontinele DR, Assunção Ribeiro da Costa RE, da Silva Magalhães MK, Vieira SC.
    • Breast Dis. 2022;41(1):249-254. doi: 10.3233/BD-210082.